To view or add a comment, sign in Novo Nordisk has received CDSCO approval for its blockbuster drug Ozempic, completing its semaglutide portfolio in India as the obesity-treatment market expands rapidly Sanket Koul reports #NovoNordisk #Ozempic #Obesity #WeightLoss #Pharma To view or add a comment, sign in The US FDA is set to decide on Novo Nordisks new drug application for oral semaglutide 25 mg for chronic weight management in adults living with obesity or overweight later this year
As regards antral length, the current results revealed a significant increase in antral length in the patients who received KD with L-carnitine supplementation after intervention in comparison to the time of enrolment, while there was no significant change noticed in the non-supplemented group
Compounded tirzepatide with niacinamide is not FDA-approved and should only be used when prescribed by a licensed healthcare provider
May 5, 2020
GLP-1 Metabolic Bundle Our most comprehensive system for glucose management
Thats why Sundratas program includes medical, regenerative, and aesthetic support to ensure you look and feel your best from the inside out
